Notice to persons with angina: a lot of sprays of nitroglycerin is the subject of a recall

News 2 September, 2017
  • Photo courtesy

    QMI agency

    Saturday, September 2, 2017 00:04

    UPDATE
    Saturday, September 2, 2017 00:04

    Look at this article

    OTTAWA – The canadian pharmaceutical Apotex recalls one lot of its spray sublingual nitroglycerin, because the pump may malfunction and not to administer the drug.”

    The voluntary recall was announced by Health Canada on the Friday evening.

    “Nitroglycerin is a prescription drug used to control acute attacks of angina (chest pain), says the ministry in a press release. The pump is intended for administration under the tongue of the medicine by spraying. Patients with angina who do not receive nitroglycerin are at risk of having a heart attack.”

    The affected product bears the name of Apo-Nitroglycerin with concentration of 0.4 mg per metered dose to a total of 200 metered doses per bottle. The expiry date is January 2019.

    Health Canada advises consumers affected by this recall to return one of the units of the product from the batch referred to the pharmacy and ask for a replacement product. It is also recommended to consult a health care professional about all alternative products available.